This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: J David Gangemi: Innovator in Antiviral Treatments
Introduction
J David Gangemi is a notable inventor based in Columbia, SC (US). He has made significant contributions to the field of pharmaceuticals, particularly in antiviral treatments. His innovative work has the potential to impact the treatment of viral diseases and cancer.
Latest Patents
Gangemi holds a patent for an "Antiviral combination, and method of treatment." This patent describes a synergistic pharmaceutical combination preparation that includes a hybrid alpha-interferon derived from human interferon-alpha-D and -B gene fragments, along with a muramylpeptide. The preparation is designed to treat viral diseases and reduce the formation of metastases in certain tumors.
Career Highlights
Throughout his career, Gangemi has been associated with Ciba-Geigy Corporation, where he has contributed to various research and development projects. His work has focused on creating effective treatments that leverage the body's immune response to combat viral infections.
Collaborations
Gangemi has collaborated with several professionals in the field, including his coworker Heinz-Kurt Hochkeppel. Their joint efforts have led to advancements in antiviral therapies and have fostered innovation within the pharmaceutical industry.
Conclusion
J David Gangemi's contributions to antiviral treatments exemplify the importance of innovation in medicine. His work continues to pave the way for new therapeutic options that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile